Objective/Background:
Introduction
The National Institute of Mental Health (NIMH) Research Units on Pediatric Psychopharmacology (RUPP) Autism Network reported the intention-to-treat (ITT) analyses of an 8-week, double-blind, placebo-controlled trial of risperidone for irritability (aggression, self-injury, and severe tantrums) in autistic disorder (autism) (RUPP Autism Network 2002) . The effect size d was 1.2 in favor of risperidone on the main outcome measure, the Irritability subscale of the Aberrant Behavior Checklist (ABC) (Aman et al. 1985) . This paper explores possible moderators, mediators, and other predictors of that effect.
Moderators can be patient, family, or other contextual characteristics that predict the differential effects of treatment choice and thus suggest a way to match patients to treatments. The seminal Baron and Kenny (1986) guidelines for defining moderators specified only that an interaction between the suspected moderator and independent variable (in this case, treatment) occur. However, the MacArthur Foundation Network subgroup (Kraemer et al. 2002; Kraemer et al. 2008 ) introduced widely accepted modifications to this definition. The MacArthur guidelines state that to be considered a moderator, a variable must: (1) Have temporal precedence, (2) be independent from treatment, and (3) interact significantly with treatment in the model of analysis. These more stringent guidelines were adopted here as requirements for moderation.
A mediator is a postrandomization variable that is associated with treatment and may help to explain the mechanism through which the independent variable is affecting the dependent variable. Theoretically, the treatment variable affects the mediator, which, in turn, affects the outcome variable (Holmbeck 1997) . Given a factorial model, the MacArthur guidelines for mediation require: (1) The temporal precedence of treatment, (2) an association between the mediator and treatment (in this case, point-biserial correlation), and (3) a main effect of the mediator or an interaction between the mediator and treatment. Although this definition does not require a significant effect of treatment on outcome, the absence of such treatment effect would be unusual if the definition is met.
Moderator and mediator analyses in this paper were mainly exploratory, with few a priori hypotheses. However, we did expect that better treatment compliance (measured via tablet count and medication diary) and dose would be related to the effectiveness of risperidone.
Methods
The design, assessment and ITT results of the RUPP Autism Network risperidone study have been detailed elsewhere edition (DSM-IV) (American Psychiatric Association 1994) autistic disorder and severe irritability. Primary ITT analyses showed highly significant effects of risperidone on both of the primary outcome measures: The ABC Irritability subscale (57% decrease vs. 14% decrease) and the Clinical Global Impressions-Improvement (CGI-I) (75.5% vs. 11.5% with CGI-I less than 3). The effect size (Cohen d) on the ABC Irritability subscale was 1.2 at 8 weeks.
Using the primary outcome measure of the ABC Irritability subscale score, we explored the effects of possible moderators and mediators. Casting a wide net, we included demographic characteristics, diagnostic measures, symptom severity, and exploratory laboratory analyses (prolactin, leptin, and mineral assays). Mineral assays were included because of reports of mineral abnormalities in autism, especially zinc and copper and their ratio (Faber et al. 2009 ) and such related proteins as ferritin and ceruloplasmin (Chauhan et al. 2004 ) and because prolactin, known to be increased by risperidone, has been suspected of increasing ceruloplasmin (DiSilvestro 1986). First, potential moderators (Table 1 ) and mediators (Table 2) were entered into respective correlation matrices to check for collinearity. By predetermination, any correlation of 0.5 or stronger would result in combining the variables or discarding one. Most correlations were well below 0.2 and nonsignificant. The exceptions were parental education and income, which were correlated with each other (r=0.40, p < 0.0001), and the Autism Diagnostic Interview-Revised (ADI-R) (Lord et al. 1994 ) Stereotypy subscale, which correlated both with the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) (Scahill et al. 1997) at 0.22 (p < 0.03) and with the ADI-R Communication Impairment subscale at 0.27 ( p < 0.01). Because all correlations were below r = 0.5, all variables were considered in the analysis.
The suspected moderators and mediators were centered according to the guidelines recommended by Kraemer and Blasey (2004) . The ordinal moderators were centered around their respective medians, while the binary moderators (and treatment group) were set to -0.5 or 0.5. As change scores, mediators were all considered to be deviations from zero. Centering the data allows the effects to be evaluated at the level of the independent variable that is representative of the group and helps to diminish the effects of multicollinearity (Kraemer and Blasey 2004) .
Some variables presented with special considerations for data analysis. For potential mediators, change scores were calculated as percent change (absolute change divided by baseline value) for ease of comparison. For medication-related variables, dose and compliance, different methods were used. Dose, considered to be the prescribed dosage of risperidone, was to be maintained during the final 4 weeks of treatment at the child's optimal dose. This optimal dose was analyzed as both absolute mg/day and mg/kg per day. 
